Disclosed are tumor associated antigens from cadherin-3 (CDH3) having less than 15 amino acids and comprise an amino acid sequence selected from SEQ ID NO: 19, 22, 30, 34 or 358. The TAA are used in methods for inducing a cytotoxic T-cell response and in cancer vaccines for inhibiting proliferating cells expressing CDH3 (SEQ ID NO: 1).